Search

Your search keyword '"Brandi, G"' showing total 1,327 results

Search Constraints

Start Over You searched for: Author "Brandi, G" Remove constraint Author: "Brandi, G"
1,327 results on '"Brandi, G"'

Search Results

1. Immune-Based Combination Therapies for Advanced Hepatocellular Carcinoma

2. Systemic liquidity contagion in the European interbank market

4. Evaluating the Sum of Eye and Motor Components of the Glasgow Coma Score As a Predictor of Extubation Failure in Patients with Acute Brain Injury

5. On the interplay between multiscaling and stocks dependence

6. Clinical practice and effect of carbon dioxide on outcomes in mechanically ventilated acute brain-injured patients: a secondary analysis of the ENIO study

9. Utilization of mechanical power and associations with clinical outcomes in brain injured patients: a secondary analysis of the extubation strategies in neuro-intensive care unit patients and associations with outcome (ENIO) trial

10. Individualized Thresholds of Hypoxemia and Hyperoxemia and their Effect on Outcome in Acute Brain Injured Patients: A Secondary Analysis of the ENIO Study

11. Risk factors of extubation failure in neurocritical patients with the most impaired consciousness

13. Clinical impact of relative dose intensity of cabozantinib during the first 8 weeks and of subsequent dose reductions in patients with unresectable hepatocellular carcinoma

14. Outcomes of Sorafenib and Metronomic Capecitabine in Child-Pugh B patients with advanced hepatocellular carcinoma in the era of immunotherapy: A real-life comparison with best supportive care

15. Bone metastases in biliary cancers: A multicenter retrospective survey

17. Extubation in neurocritical care patients: the ENIO international prospective study

18. Regret affects the choice between neoadjuvant therapy and upfront surgery for potentially resectable pancreatic cancer

19. Association between asbestos exposure and pericardial and tunica vaginalis testis malignant mesothelioma: a case–control study and epidemiological remarks

21. Combining immune checkpoint inhibitors with locoregional therapies in hepatocellular carcinoma

26. The Fifth Circuit Takes a Fresh Look at ERISA Benefit Claims Review Standard.

27. 59P Efficacy of derazantinib in intrahepatic cholangiocarcinoma (iCCA) patients with FGFR2 fusions, mutations or amplifications

28. 181P A randomized controlled trial on the efficacy of supervised exercise training in reducing IGF-1 levels in breast cancer survivors of the Movis’ cohort

30. Authors’ response: Mezei et al's 'comments on a recent case-control study of malignant mesothelioma of the pericardium and the tunica vaginalis testis'

32. Active breaks: a strategy to counteract sedentary behaviors for Health Promoting Schools. A discussion on their implementation in Italy.

38. Intensive follow-up program and oncological outcomes of 278 biliary tract cancer patients after curative intent surgery: A single-center retrospective experience

42. Use of hormones in doping and cancer risk

43. Second-line treatment in advanced biliary tract cancer: Today and tomorrow

45. 47P Derazantinib for patients with intrahepatic cholangiocarcinoma harboring FGFR2 fusions/rearrangements: Primary results from the phase II study FIDES-01

48. PO-1236 Stereotactic body radiotherapy in unresectable intrahepatic cholangio-carcinoma: a systematic review

49. P-69 Intensive follow-up program and oncological outcomes of 278 biliary tract cancer patients after curative intent surgery: A single-center retrospective experience

Catalog

Books, media, physical & digital resources